This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

Clinical trial NCT06756451 · RECRUITING

Trial details

NCT number: NCT06756451
Sponsor: Nanjing RegeneCore Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2025-03-25
Primary completion: 2028-04-08
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.